Combined PET and biopsy evidence of marrow involvement improves progno…
페이지 정보
본문
Cerci JJ, Györke T, Fanti S, Paez D, Meneghetti JC, Redondo F, Celli M, Auewarakul C, Rangarajan V, Gujral S, Gorospe C, Campo MV, Chung JK, Morris TP, Dondi M, Carr R; IAEA Lymphoma Study Group.
PMID:25214642
- 이전글Secular trends in the prognostic factors for papillary thyroid cancer. 16.12.26
- 다음글Radioiodine therapy in differentiated thyroid cancer: the first targeted therapy in oncology. 16.12.26
댓글목록
등록된 댓글이 없습니다.